Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Hepatic neoplasms malignant
ADR ID BADD_A02011
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.07      Hepatobiliary neoplasms malignant and unspecified
16.07.02      Hepatic neoplasms malignant
Description Not Available
MedDRA Code 10019703
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Not Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01701Pemetrexed--
BADD_D01765Phenytoin0.000574%
BADD_D01817Pramipexole--
BADD_D01818Pramipexole dihydrochloride--
BADD_D01824Pravastatin--
BADD_D01825Pravastatin sodium--
BADD_D01835Pregabalin--
BADD_D01858Propagermanium--
BADD_D01898Rabeprazole0.000391%
BADD_D01906Raltegravir potassium--
BADD_D01913Ranitidine0.012044%
BADD_D01922Regorafenib0.008473%
BADD_D01933Ribavirin0.407451%
BADD_D01938Rifaximin0.001286%
BADD_D01952Ritonavir0.000735%
BADD_D01954Rivaroxaban0.000063%
BADD_D01955Rivastigmine--
BADD_D02026Simvastatin--
BADD_D02029Sitagliptin0.000186%
BADD_D02053Sofosbuvir0.042057%
BADD_D02058Sorafenib0.063766%
BADD_D02066Spironolactone0.000073%
BADD_D02105Tacrolimus0.003713%
BADD_D02147Telmisartan0.000521%
BADD_D02154Tenofovir0.066886%
BADD_D02170Testosterone--
BADD_D02230Tizanidine--
BADD_D02231Tizanidine hydrochloride--
BADD_D02236Tofacitinib--
BADD_D02246Tolvaptan0.000262%
The 3th Page    First    Pre   3 4    Next   Last    Total 4 Pages